Chronic endothelin receptor antagonism prevents coronary vasa vasorum neovascularization in experimental hypercholesterolemia
- 1 May 2002
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 39 (9) , 1555-1561
- https://doi.org/10.1016/s0735-1097(02)01798-9
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Endothelin in Cardiovascular Disease: From Atherosclerosis to Heart FailureJournal of Cardiovascular Pharmacology, 2000
- Coronary Endothelial Function Is Preserved With Chronic Endothelin Receptor Antagonism in Experimental Hypercholesterolemia In VitroArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Chronic Endothelin Receptor Antagonism Preserves Coronary Endothelial Function in Experimental HypercholesterolemiaCirculation, 1999
- Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia.Journal of Clinical Investigation, 1998
- Angiotensin II Increases Tissue Endothelin and Induces Vascular HypertrophyCirculation, 1997
- Angiotensin II Increases Vascular and Renal Endothelin-1 and Functional Endothelin Converting Enzyme Activityin Vivo:Role of ETAReceptors for Endothelin RegulationBiochemical and Biophysical Research Communications, 1997
- Angiotensin converting enzyme inhibition modulates endogenous endothelin in chronic canine thoracic inferior vena caval constriction.Journal of Clinical Investigation, 1996
- Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs.Circulation, 1993
- Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells.Hypertension, 1992
- Induction of Endothelin Secretion by Angiotensin IIJournal of Cardiovascular Pharmacology, 1991